Recombinant multi-species MAGEA3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAGEA3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. [provided by RefSeq, Jul 2008]
The Alternative Names of target: Antigen MZ2-D,CT1.3,Cancer/testis antigen 1.3 (CT1.3),HIP8,HYPD,MAGE-3 antigen,MAGE3,MAGEA3,MAGEA6,Melanoma-associated antigen 3

Target products collectionGo to MAGEA3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T51693-Ag-1/ GM-Tg-hg-T51693-Ag-2 Human MAGEA3 protein Human
GM-Tg-rg-T51693-Ag-1/ GM-Tg-rg-T51693-Ag-2 Rat MAGEA3 protein Rat
GM-Tg-mg-T51693-Ag-1/ GM-Tg-mg-T51693-Ag-2 Mouse MAGEA3 protein Mouse
GM-Tg-cynog-T51693-Ag-1/ GM-Tg-cynog-T51693-Ag-2 Cynomolgus/Rhesus macaque MAGEA3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T51693-Ag-1/ GM-Tg-felg-T51693-Ag-2 Feline MAGEA3 protein Feline
GM-Tg-cang-T51693-Ag-1/ GM-Tg-cang-T51693-Ag-2 Canine MAGEA3 protein Canine
GM-Tg-bovg-T51693-Ag-1/ GM-Tg-bovg-T51693-Ag-2 Bovine MAGEA3 protein Bovine
GM-Tg-equg-T51693-Ag-1/ GM-Tg-equg-T51693-Ag-2 Equine MAGEA3 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T51693-Ag-1/ GM-Tg-hg-T51693-Ag-2; GM-Tg-rg-T51693-Ag-1/ GM-Tg-rg-T51693-Ag-2;
GM-Tg-mg-T51693-Ag-1/ GM-Tg-mg-T51693-Ag-2; GM-Tg-cynog-T51693-Ag-1/ GM-Tg-cynog-T51693-Ag-2;
GM-Tg-felg-T51693-Ag-1/ GM-Tg-felg-T51693-Ag-2; GM-Tg-cang-T51693-Ag-1/ GM-Tg-cang-T51693-Ag-2;
GM-Tg-bovg-T51693-Ag-1/ GM-Tg-bovg-T51693-Ag-2; GM-Tg-equg-T51693-Ag-1/ GM-Tg-equg-T51693-Ag-2
Products Name MAGEA3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MAGEA3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAGEA3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.